See today's BioWorld
To read the full story, subscribe or sign in.

Billion-dollar deals soar as M&As struggle

Feb. 11, 2022
By Karen Carey
An increasing number and rising value of high-money biopharma deals has placed early 2022 above all recent years, even though there are fewer partnerships overall.
BioWorld Analysis and data insight Deals and M&A